Product Information
- (3b,5b,12b)-3-[(O-3-O-Acetyl-2,6-dideoxy-b-D-ribo-hexopyranosyl-(14)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(14)-2,6-dideoxy-b-D-ribo- hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide
- (3β,5β,12β)-3-[(O-3-O-Acetyl-2,6-dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide
- 3'''-Acetyldigoxin
- 3-{[3-O-acetyl-2,6-dideoxyhexopyranosyl-(1->4)-2,6-dideoxyhexopyranosyl-(1->6)-2,4-dideoxyhexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide
- Acetyl-digoxin-alpha
- Card-20(22)-enolide, 3-((O-3-O-acetyl-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.4)-O-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1.4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
- Card-20(22)-enolide, 3-[(O-3-O-acetyl-2,6-dideoxy-β-<span class="text-smallcaps">D</smallcap>-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-<smallcap>D</smallcap>-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-<smallcap>D</span>-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-
- Desglucolanatoside C
- Digorid A
- Digoxigenin + zuckerkette wie bie acetyl-digitoxin A
- See more synonyms
- Digoxigenin + zuckerkette wie bie acetyl-digitoxin A [German]
- Digoxin, 3'''-acetate
- Digoxin, acetate, alpha-
- Digoxin, acetyl-
- Digoxin, α-acetate
- Digoxin, α-acetyl-
- Lanadigin
- Lanatilin
- Sandolanid
- alpha-Acetyldigoxin
- α-Acetyldigoxin
- (3β,5β,12β)-3-[(O-3-O-Acetyl-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide
- Card-20(22)-enolide, 3-[(O-3-O-acetyl-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-
Digoxin is a pharmaceutical drug that is used to manage congestive heart failure and ventricular arrhythmias. It binds to the peptide receptors in the cardiac muscle cells, which leads to an increase in the force of contraction and a decrease in the rate of cell depolarization. Digoxin may also be effective in treating inflammatory lesions and other conditions caused by enzyme inhibitors. The binding affinity of digoxin for these receptors is increased when it is acetylated at its beta-position. This change can be detected by uv absorption and can be quantified using high-performance liquid chromatography (HPLC). A purified preparation of acetyl digoxin has been shown to have biochemical properties similar to those of natural digoxin.
Chemical properties
Technical inquiry about: 3D-OA16441 a-Acetyl digoxin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
